Review
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.
Eur. J. Cancer. 2006 Oct 1; 42 (15): 2433-53.
Review
The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
Paediatr Drugs. 2003 Jan 1; 5 (10): 673-84.
Practice Guideline
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.
Eur. J. Cancer. 2011 Jan 1; 47 (1): 8-32.